Haemonetics | HAE - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Baxter International USD 1.14B 251M 2026-06
Becton, Dickinson and Co. USD 2.32B 161M 2026-06
Boston Scientific USD 3.82B 210M 2026-06
Cerus USD 33.33M 8.66M 2024-12
Cooper Companies USD 735.4M 40.2M 2026-03
Fresenius EUR 1.55B 16M 2026-06
Fresenius Medical Care EUR 1.31B 130.98M 2026-06
Globus Medical USD 548.17M 51.91M 2026-06
Haemonetics USD 202.8M 4.59M 2026-06
ICU Medical USD 235.05M 28.83M 2026-06
Intuitive Surgical USD 2.02B 193.4M 2026-06
Medtronic USD 6.36B 355M 2026-06
Merit Medical Systems USD 215.17M 30.37M 2026-06
Neogen USD 99M 7.7M 2025-12
OraSure Technologies USD 11.34M 435K 2025-12
Plus Therapeutics 1.37M 30K 2025-12
Quidel USD 223.9M 315.7M 2026-06
ResMed USD 861.22M 29.76M 2026-06
STAAR Surgical USD 69.73M 868K 2026-06
Steris USD 684.2M 12.9M 2026-06
Stryker USD 4.5B 688M 2026-06
Teleflex USD 331.71M 24.28M 2026-06
Terumo JPY 178.54B 29.52B 2026-06
Thermo Fisher Scientific USD 4.49B 146M 2026-03
US Physical Therapy USD 41.94M 9.19M 2026-06
Zimmer Biomet Holdings USD 1.36B 149.4M 2026-06